医药行业分析
- (2021-09-07)
NeuExcell Therapeutics 和 Spark Therapeutics 发布杀青研讨单干协定,为亨廷顿跳舞症开辟新型基因疗法
(2021-09-07)- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-06)
- (2021-09-06)
- (2021-09-06)
- (2021-09-06)
- (2021-09-06)
- (2021-09-06)
- (2021-09-06)
- (2021-09-06)
- (2021-09-06)
- (2021-09-03)
- (2021-09-03)
- (2021-09-03)
- (2021-09-03)
- (2021-09-03)
- (2021-09-03)
- (2021-09-03)
- (2021-09-03)
MUCOSAL IMMUNOL:PRKAR2A缺失可通过添加IFN刺激的基因表白和调理肠道微生物群来维护小鼠免受试验性结肠炎的损害
(2021-09-03)- (2021-09-03)
- (2021-09-03)
- (2021-09-03)
- (2021-09-02)
- (2021-09-02)
- (2021-09-02)
- (2021-09-02)
- (2021-09-02)
- (2021-09-02)
- (2021-09-02)
- (2021-09-02)
- (2021-09-02)
- (2021-09-02)
- (2021-09-02)
- (2021-09-02)
- (2021-09-02)
- (2021-09-02)
- (2021-09-01)
- (2021-09-01)
- (2021-09-01)
- (2021-09-01)
- (2021-09-01)
- (2021-09-01)
- (2021-09-01)